COVID-19 Vaccine AstraZeneca - Product Information as approved by the CHMP on 29 January 2021, pending endorsement by the European Commission
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
product-information
medication.label.permit_validity
First published: 2021-01-29T16:30:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live